Quote & Headlines
StockTalk
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Fund Clones Q3 2009 Rebalance UpdateAlphaClone • Thu, Dec 3, 2009
-
A Look at M & A Arbitrage ActivityJae Jun • Wed, Apr 8, 2009
-
Gilead Follows Its Heart, Sweeps CV Away for $1.4BEP Vantage • Fri, Mar 13, 2009
-
Why Is Gilead Buying CV Therapeutics?Ockham Research • Thu, Mar 12, 2009
-
CV Tells Astellas to Take a Hike: Looks to GileadEben Tessari • Thu, Mar 12, 2009
-
Astellas Announces Offer to Buy CV TherapeuticsEben Tessari • Mon, Mar 2, 2009
To learn more about Seeking Alpha Pro, click here.
-
Will CV Therapeutics Get a Higher Price from Astellas?Kirk Shinkle • Tue, Jan 27, 2009
-
CV Therapeutics: Loeb's Third Point Discloses 9.9% StakeLon Juricic • Fri, May 18, 2007
-
Why the CV Therapeutics Sell-off Was OverdoneTop Textrader • Fri, Mar 9, 2007
-
Ranexa Won't Treat Heart Attacks, CV Therapeutics Falls 24%SA Editor Judy Weil • Thu, Mar 8, 2007
-
CV Therapeutics Trial Results: Enough To Drive Profitability?Notable Calls • Wed, Mar 7, 2007
-
CV Therapeutics: Last Chance for a Tax LossTravis Johnson • Fri, Dec 29, 2006
-
Fund Clones Q3 2009 Rebalance UpdateAlphaClone • Thu, Dec 3, 2009
-
A Look at M & A Arbitrage ActivityJae Jun • Wed, Apr 8, 2009
-
Gilead Follows Its Heart, Sweeps CV Away for $1.4BEP Vantage • Fri, Mar 13, 2009
-
Why Is Gilead Buying CV Therapeutics?Ockham Research • Thu, Mar 12, 2009
-
CV Tells Astellas to Take a Hike: Looks to GileadEben Tessari • Thu, Mar 12, 2009
-
Astellas Announces Offer to Buy CV TherapeuticsEben Tessari • Mon, Mar 2, 2009
-
CV Therapeutics, Inc. Q3 2008 Earnings Call TranscriptWed, Nov 19, 2008
-
CV Therapeutics, Inc. Q2 2008 Earnings Call TranscriptThu, Jul 31, 2008
-
CV Therapeutics Inc. Q1 2008 Earnings Call TranscriptFri, Apr 25, 2008
-
CV Therapeutics Inc. Q4 2007 Earnings Call TranscriptWed, Feb 27, 2008
-
CV Therapeutics Q3 2007 Earnings Call TranscriptTue, Nov 6, 2007
There are no News articles on CVTX.